In Vivo Antimalarial Effects of Iranian Flora Artemisia khorassanica against Plasmodium berghei and Pharmacochemistry of its Natural Components
-
H Nahrevanian
,
B Kazemi
,
M Nazem
,
H Nazem
,
M Amini
Abstract
Background: The aim of this study was to evaluate the antimalarial effects of Iranian flora Artemisia khorassanica against Plasmodium berghei in vivo and pharmacochemistry of its natural components.
Methods: The aerial parts of Iranian flora A. khorasanica were collected at flowering stage from Khorassan Province, northeastern Iran in 2008. They were air-dried at room temperature; powder was macerated in methanol and the extract defatted in refrigerator, filtered, diluted with water, then eluted with n-hexane and finally non-polar components were identified through Gas Chromatography and Mass Spectroscopy (GC-MS). Toxicity of herbal extracts was assessed on naïve NMRI mice, and its anti-malarial efficacy was investigated on infected Plasmodium berghei animals. This is the first application on A. khorssanica extract for treatment of murine malaria. The significance of differences was determined by Analysis of Variances (ANOVA) and Student's t-test using Graph Pad Prism Software.
Results: The herbal extract was successfully tested in vivo for its anti-plasmodial activity through artemisin composition, which is widely used as a standard malaria treatment.
Conclusion: Although, this study confirmed less anti-malarial effects of A. khorssanica against murine malaria in vivo, however there are some evidences on reducing pathophysiology by this medication. In complementary assay, major components were detected by GC-MS analysis in herbal extract including chrysanthenone (7.8%), palmitic acid (7.4%) and cis-thujone (5.8%). The most retention indices of the component are given as n-eicosane, palmitic acid and n-octadecane.
Hardman JG, Limbird LE. Drugs used in the chemotherapy of malaria. In: Brunton L, Lazo J, Parker K. editors. The Goodman and Gilman's pharmacological bases of therapeutics. 10th ed. New York, USA: Mc Graw-Hill; 2001. P. 1069-1100.
Peter IT, Anatoli VK. The current global malaria situation; Malaria parasite biology, pathogenesis and protection. 1st ed. ASM Press. WDC 1998.
Martin SA, Bygbjerg IC, Joil GB. Are multilateral malaria research and control programs the most successful? Lessons from the past 100 years in Africa. Am J Trop Med Hyg. 2004; 2: 268-78.
Miller LH, Good MF, Million G. Malaria pathogenesis. Biochem Systemat Ecolog. 1994; 264: 1878-83.
More CM. Reaching maturity-25 years of the TDR. Parasitol Today. 2002; 16: 522-8.
David AF, Philip JR, Simon LC, Reto B, Solomon N. Antimalarial drug discovery: Efficacy models for compound screening. Nat Rev. 2004; 3: 509-20.
Turschner S, Efferth T. Drug resistance in Plasmodium: natural products in the fight against malaria. Mini Rev Med Chem. 2009; 9: 206-12.
Olliaro P, Cattani J, Wirth D. Malaria, the submerged disease. J Am Med Assoc. 1996; 275: 230–3.
White N, Olliaro P. Strategies for the prevention of anti-malarial drug resistance: rationale for combination therapy for malaria. Parasitol Today. 1996; 12: 399–401.
He SP, Tan GY, Li G, Tan WM, Nan TG, Wang BM, Li ZH, Li QX. Development of a sensitive monoclonal antibody-based enzymelinked immunosorbent assay for the antimalaria active ingredient artemisinin in the Chinese herb Artemisia annua L. Anal Bioanal Chem. 2009; 393: 1297-303.
Willoughby JA Sr, Sundar SN, Cheung M, Tin AS, Modiano J, Firestone GL. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression. J Biol Chem. 2009; 284: 2203-13.
Arsenault PR, Wobbe KK, Weathers PJ.Recent advances in artemisinin production through heterologous expression. Curr Med Chem. 2008; 15: 2886-96.
Klayman DL, Lin AJ, Acton N, Scovill JP, Hock JM, Milhous WK, Theoharides AD. Isolation of artemisinin (qinghaosu) from Artemisia annua growing in the United States. J Nat Prod. 1984; 47: 715-7.
Ro DK, Ouellet M, Paradise EM, Burd H, Eng D, Paddon CJ, Newman JD, Keasling JD. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnol. 2008; 8: 83.
de Ridder S, van der Kooy F, Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing countries. J Ethnopharmacol. 2008; 120: 302-14.
Arab HA, Rahbari S, Rassouli A, Moslemi MH, Khosravirad F. Determination of artemisinin in Artemisia sieberi and anticoccidial effects of the plant extract in broiler chickens. Trop Anim Health Prod. 2006; 38: 497-503.
Romero MR, Serrano MA, Vallejo M, Efferth T, Alvarez M, Marin JJ. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med. 2006; 72: 1169-74.
Heywood VH, Humphries CJ. Anthemideae systematic review. In: Heywood VH, Harbord JB, Turner BL. Editors. The biology and chemistry of the compositae. 2nd ed. Academic Press, London, 1977; Chapter 31, p. 852- 88.
White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008; 320: 330-4.
Liu C, Zhao Y, Wang Y. Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug. Appl Microbiol Biotechnol. 2006; 72: 11-20.
Rechinger KH. Artemisia in Flora Iranica. In: Rechinger KH, Hedge IC, editors. Compositae, Chapter 158, Akademische Druck and Verlagsanatalt, Graz, Austria, 1986; p. 214.
Rezaeinodehi A, Khangholi S. Chemical composition of the essential oil of Artemisia absinthium growing wild in Iran. Pak J Biol Sci. 2008; 11: 946-9.
Khangholil S, Rezaeinodehi A. Effect of drying temperature on essential oil content and composition of sweet wormwood (Artemisia annua) growing wild in Iran.Pak J Biol Sci. 2008; 11: 934-7.
Maleki A, Zarasvand MA. Heavy metals in selected edible vegetables and estimation of their daily intake in Sanandaj, Iran. SE Asn J Trop Med Pub Health. 2008; 39: 335-40.
Asgary S, Dinani NJ, Madani H, Mahzouni P. Ethanolic extract of Artemisia aucheri induces regression of aorta wall fatty streaks in hypercholesterolemic rabbits. Pharmazie. 2008; 63: 394-7.
Jalali Heravi M, Sereshti H. Determination of essential oil components of Artemisia haussknechtii Boiss. using simultaneous hydrodistillation- static headspace liquid phase microextraction-gas chromatography mass spectrometry. J Chromatog A. 2007; 1160: 81-9.
Farzaneh M, Ahmadzadeh M, Hadian J, Tehrani AS. Chemical composition and antifungal activity of the essential oils of three species of Artemisia on some soil-borne phytopathogens. Commun Agric Appl Biol Sci. 2006; 71(Pt B): 1327-33.
Bagheri R, Chaichi MR, Mohseni- Saravi M, Amin GR, Zahedi G. Grazing affects essential oil compositions of Artemisia sieberi Besser. Pak J Biol Sci. 2007; 10: 810-13.
Gu JD, Chen KX, Jiang HL, Ji RY. A model molecule study of the Ocentered and the C-centered free radical intermediates of artemisinin. Mol. Struct (Theochem) 1999; 459: 103.
Gu, JD, Chen KX, Jiang HL, Leszczynski J. The Radical Transformation in Artemisinin: A DFT Study. J Physical Chemistry Part A. 1999; 103: 9364.
Castilho PC, Gouveia SC, Rodrigues AI. Quantification of artemisinin in Artemisia annua extracts by 1H-NMR. Phytochem Anal 2008; 19: 329-334.
Ma C, Wang H, Lu X, Li H, Liu B, Xu G. Analysis of Artemisia annua L. volatile oil by comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. J Chromatogr A. 2007; 1150: 50-3.
Haynes RK. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem. 2006; 6: 509-37.
Vyas N, Avery BA, Avery MA, Wyandt CM. Carrier-Mediated Partitioning of Artemisinin into Plasmodium falciparum-Infected Erythrocytes. Antimicrob Agent Chemoth. 2002; 46: 105-9.
Meschnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Mol Biol Rev. 1996; 60: 301-15.
Bhattacharya A, Mishra LC, Bhasin VK. In vitro activity of artemisinin in combination with clotrimazole or heat-treated amphotericin B against Plasmodium falciparum. Am Soc Trop Med Hyg. 2008; 78: 721-8.
Meshnick SR. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol. 2002; 32: 1655–60.
Asawamahasakda W, Benakis A, Meshnick SR. The interaction of artemisinin with red cell membranes. J Lab Clin Med. 1994; 123: 757–62.
Bhisutthibhan J, Pan XQ, Hossler PA, Walker DJ, Yowell CA, Carlton J, Dame JB, Meshnick SR. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem. 1998; 273: 16192–8.
Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S. Artemisinins target the SERCA of Plasmodium falciparum. J Nature 2003; 424: 957–961.
Mercereau-Puijalon O, Fandeur T. Antimalarial activity of artemisinins: identification of a novel target? Lancet. 2003; 362: 2035–6.
Rustaiyan A, Bamoniri A, Raffatrad M, Jakupovic J, Bohlman F. Eudesmane derivatives and highly oxygenated monoterpenes from Iranian Artemisia species. Phytochem. 1987; 26: 2307-10 .
Weyerstahl P, Schneider S, Marschall H, Rustaiyan A. The essential oil of Artemisia sieberi. J Flav Frag. 1993; 8: 139-45.
Weyerstahl P, Schneider S, Marschall H, Rustaiyan A. Terpenes and Terpene Derivatives, XXXI. New Bisabolene derivatives and a Salsolene Ketone from Artemisia sieberi Bess. Liebigs Annalen der Chemie. 1993; 2: 111-6.
Rustaiyan A, Sigari H, Jakupovic J, Grenz M. A sesquiterpene lactone from Artemisia diffusa. Phytochem. 1989; 28: 2723-5.
Rustaiyan A, Zare K, Ganji MT, Sadri HA. A melampolide and two dihydro artemorin derivatives from Artemisia gypsacea. Phytochem. 1989; 28: 1535-6.
Rustaiyan A, Balalaei S, Mohammadi F, Masoudi S, Yari M. Comparison of the volatile oils of Artemisia santolina Schrenk and Artemisia gypsacea Krasch., M. Pop. et Lincz. ex Poljak. from Iran. J Ess Oil Res. 2000; 12: 330-2.
Rustaiyan A, Komeilizadeh H, Masoudi S, Monfared A, Yari M,= Kardar M, Shahgholi M. Composition of the volatile oil of Artemisia deserti Krash. and Artemisia oliveriana J. Gayex DC. from Iran. J Sci IR Irn. 2000; 11: 213-5.
Sefidkon F, Jalili A, Mirhaji T. Essential oil composition of three Artemisia spp. from Iran. J Flav Frag. 2000; 17: 150-2. 50. Morteza-Semnani K, Akbarzadeh M, Moshiri K. Essential oil composition of Artemisia fragrans Willd. from Iran. J Flav Frag. 2005; 20: 330-1.
Nematollahi F, Rustaiyan A, Larijani K, Nadimi M, Masoudi S. Essential oil composition of Artemisia biennis Wild. and Pulicaria undulate (L.) C.A. Mey., two compositae herbs growing wild in Iran. J Ess Oil Res. 2006; 18: 339-41.
Rustaiyan A, Nahrevanian H, Kazemi M. A new antimalarial agent; Effect of extracts of Artemisia diffusa against Plasmodium berghei. Pharmacog Mag. 2009; 4: 1-7.
Adams RP. Identification of Essential Oil Components by Gas Chromatography / Quadrupole Mass Spectroscopy. Allured Publishing Corporation, Carol Stream, Illinois, 2001; 61-424.
Nahrevanian H, Dascombe MJ. Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria. Parasit Immunol. 2001; 23: 491-501.
Nahrevanian H, Dascombe MJ. Expression of inducible nitric oxide synthase (iNOS) mRNA in target organs of lethal and non-lethal strains of murine malaria. Parasit Immunol. 2002; 24: 471-8.
Nahrevanian H, Farahmand M, Aghighi Z, Assmar M, Amirkhani A. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER; An Iranian strain of cutaneous leishmaniasis. Exp Parasitol. 2007; 116: 233-40.
Dascombe MJ, Nahrevanian H. Pharmacological assessment of the role of nitric oxide in mice infected with lethal and nonlethal species of malaria. Parasit Immunol. 2003; 25: 149-59.
Yazdanparast R, Shahriyary L. Comparative effects of Artemisia dracunculus, Satureja hortensis and Origanum majorana on inhibition of blood platelet adhesion, aggregation and secretion. Vascul Pharmacol. 2008; 48: 32-7.
van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci. 1999; 20: 199-205.
| Files | ||
| Issue | Vol 5 No 1 (2010) | |
| Section | Articles | |
| Keywords | ||
| Artemisia khorassanica Iran Malaria Pharmacochemistry Plasmodium berghei | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
